Delivery Order SPE2DB24D2101-SPE2DB25FKMRN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count supply) on July 28, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for WELIREG 40 mg tablets (90-count supply) on August 26, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count) on June 18, 2025, with completion expected by July 11, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal medical procurement vendor, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for Welireg 40 mg tablets (90-count units) on August 29, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive procurement for pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count) valued at $35,936.78 on September 18, 2025. This firm fixed-price delivery order, which is not subject to any set-aside designation, is scheduled for completion by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Welireg 40 mg tablets (90-count units) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 17, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. The contract is issued as a...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) on August 21, 2025, with completion targeted for September 12, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Welireg 40 mg tablets (90-count units) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation. Performance will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Welireg 40 mg tablets (90-count units) with a ceiling value of $17,968.39. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, with no set-aside designation applied. The contract represents a competitive award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMRNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for WELIREG 40 mg tablets (90-count packaging) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in the federal medical supply chain, particularly for military and veteran healthcare systems. As a critical vendor for DLA's Medical Supply Chain, the company supplies an extensive portfolio of pharmaceutical products and medical devices across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This delivery order for WELIREG tablets continues the company's ongoing fulfillment of pharmaceutical needs under its prime indefinite delivery contract framework, enabling flexible and responsive medical supply support for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 7/23/25 |